GelStat (GelStat) Accounts Payable & Accrued Expense : $1.58 Mil (As of Dec. 2008)

View and export this data going back to 1996. Start your Free Trial

What is GelStat Accounts Payable & Accrued Expense?

GelStat's quarterly accounts payable & accrued expense increased from Jun. 2008 ($1.71 Mil) to Sep. 2008 ($1.73 Mil) but then declined from Sep. 2008 ($1.73 Mil) to Dec. 2008 ($1.58 Mil).

GelStat's annual accounts payable & accrued expense increased from Dec. 2006 ($1.11 Mil) to Dec. 2007 ($1.40 Mil) and increased from Dec. 2007 ($1.40 Mil) to Dec. 2008 ($1.58 Mil).

GelStat Accounts Payable & Accrued Expense Historical Data

The historical data trend for GelStat's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GelStat Accounts Payable & Accrued Expense Chart

GelStat Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.74

0.99

1.11

1.40

1.58

GelStat Quarterly Data
	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.40	1.71	1.71	1.73	1.58

GelStat Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

GelStat (GelStat) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GelStat Corp (OTCPK:GSAC) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 SE 2nd Avenue, Suite 2000, Miami, FL, USA, 33131

Website

https://www.gelstat.com

GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.

Executives

Adrian Graham Goldfarb	director	7660 CENTURION PARKWAY, SUITE 100, JACKSONVILLE FL 32256
Donald Miller	director, officer: Chief Financial Officer
Garry N Lowenthal	officer: Chief Financial Officer	2551 38TH AVENUE NE, STE 135, MINNEAPOLIS MN 55421

GelStat (GelStat) Headlines

No Headlines